Atlas Trials

MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC

Clinical trial NCT05114213 · TERMINATED

Trial details

NCT number
NCT05114213
Sponsor
Ludwig-Maximilians - University of Munich
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2021-12-15
Primary completion
2025-11-11
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.